B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia

Hima V. Vangapandu(The University of Texas MD Anderson Cancer Center), Varsha Gandhi(The University of Texas MD Anderson Cancer Center), Michael J. Keating(The University of Texas MD Anderson Cancer Center), Ondřej Havránek(The University of Texas MD Anderson Cancer Center), Christine M. Stellrecht(The University of Texas Health Science Center at Houston), R. Eric Davis(The University of Texas MD Anderson Cancer Center), William G. Wierda(The University of Texas MD Anderson Cancer Center), Benny Abraham Kaipparettu(Children's Cancer Center), Mary Ayres(The University of Texas MD Anderson Cancer Center), Kumudha Balakrishnan(The University of Texas MD Anderson Cancer Center)
Molecular Cancer Research
August 23, 2017
10.1158/1541-7786.mcr-17-0026
Cited by 50

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
|Nature|2010|1.6k
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
|Blood|1997|1.2k
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
|The Journal of Experimental Medicine|2001|1.1k